Unlocking the Secrets of Ovarian Reserve and Anti-Mullerian Hormone
Anti-mullerian hormone (AMH) is commonly used as a marker to assess ovarian reserve and reproductive potential.
Category: Womens Health
Womens Health
Latest
Womens Health
Latest
Are Older Women Being Over-Screened for Cervical Cancer?
A new study suggests that women over the age of 65 may be undergoing unnecessary cervical cancer screenings.
Womens Health
Latest
Women’s Heart Centers Improve Accurate Diagnoses & Outcomes
Declines in cardiovascular disease death rates stalled for mid-life women compared to men, suggesting sex-specific approaches may be needed.
Change of Venue: How Oklahoma Successfully Relocated Its Public Health Laboratory
The Oklahoma State Public Health Laboratory transferred to a new facility in the midst of the COVID-19 crisis.
Read More
Preeclampsia Linked to Increased Markers of Brain Damage, Inflammation
Researchers found that women with a history of severe preeclampsia have more markers linked to brain cell damage and inflammation.
Read More
New Study Assesses Regulatory Frameworks on Embryo Testing for Genetic Conditions
Due to advancements in medical technology, embryos can be genetically screened before being implanted in the womb via in-vitro fertilization.
Read More
Sperm Screening Might Detect Harmful Mutations Early
Screening sperm may aid in identifying harmful new genetic mutations and help fertility specialists prevent them from passing on to offspring.
Read More
This Gene May Explain Why Women’s Heart Attacks Go Undiagnosed
Many current symptom profiles and lab tests for heart disease do not accurately reflect known...
Read More
Yourgene Health Launches Fetal Fraction Enrichment Solution
Yourgene Health launched a new solution which aims to help NIPT providers reduce no-call rates by optimizing average fetal fraction.
Read More
Novel Assay for Early Detection of Ovarian Cancer Outperforms CA125, Research Shows
Mercy BioAnalytics’ Mercy Halo Ovarian Cancer assay outperformed CA125 when identifying those with early high-grade serious ovarian cancer.
Read More
Biomarker Panel May Help Predict Gestational Diabetes Early in Pregnancy
Researchers may have identified an effective way of detecting gestational diabetes mellitus (GDM) earlier in pregnancy.
Read More
Sera Prognostics’ Data Shows Benefit of Preterm Birth Risk Assessment Tool
Sera Prognostics, a company focused on curbing preterm birth risks, demonstrated data on the health and economic benefits of its PreTRM test.
Read More
Premier Medical Laboratory Services Now Offering Noninvasive Prenatal Testing
Premier Medical Laboratory Services has added Noninvasive Prenatal Testing to its line of diagnostic testing and risk screening services.
Read More
Health Screening, Genetic Tests Might Identify Those with Premature Heart Disease Risk
Health screening and genetic tests might identify more than one million U.S. adults who carry a gene for familial hypercholesterolemia.
Read More
Gynecologic Disorders Suggests New Screening Options for Heart Diseases, Cancer
Women suffering from three gynecologic disorders may be protected from future heart disease if they carry a specific common genetic variant.
Read More
Supplement May Treat Menopausal Symptoms, Lower Risk of Alzheimer’s in Women
A clinical trial is testing a plant-based alternative to hormone therapy to reduce menopausal symptoms and the risk of Alzheimer’s in women.
Read More
Blood Test Differentiates Severe COVID from Preeclampsia in Pregnant Women
Researchers conducted a study where they questioned the extent to which Preeclampsia and COVID share biological characteristics.
Read More
FDA Warns of Risks Associated with Non-Invasive Prenatal Screening Tests
The FDA is warning the public of the risk of false results, inappropriate use, and inappropriate interpretation of results with NIPS tests.
Read More